What is the Boel Method? An Introduction to AcuNova Acupuncture
When people first hear about the Boel Method, they often ask the same question: Is this just acupuncture? The short answer is no — and the longer answer explains why the distinction matters for anyone considering complementary care for chronic eye conditions or neurological complaints.
The Boel Method is a clinical acupuncture protocol developed at the Boel Acupuncture School in Denmark. The school was founded by John Boel Sr. in 1979 and has been led for the past three decades by his son, John Boel Jr., who has trained somewhere between 150 and 250 acupuncturists each year since 1988. Through the school's worldwide network of graduates, the method has been used to treat an estimated 30 million patients globally. Its trademarked clinical protocol is called AcuNova.
What makes it different from generalized acupuncture
Most people imagine acupuncture as needles placed along meridian lines on the back, shoulders, or trunk. That is one form. The Boel Method works differently: it relies primarily on microsystem points located on the hands and feet, with selective use of points around the eyes and scalp.
A microsystem is a region of the body that, in traditional Chinese medical theory and in some modern clinical observation, maps onto the rest of the organism. The ear has its own microsystem (auriculotherapy). So do the hands, the feet, and parts of the scalp. The Boel Method's contribution is a structured protocol — refined over more than 40 years of clinical practice — that specifies which microsystem points correspond to which conditions, in what sequence, and with what stimulation pattern.
For practitioners trained outside the Boel tradition, the difference is striking. A classical TCM treatment for vision loss might involve points on the bladder meridian (running down the back) and the gallbladder meridian (running along the side of the head). An AcuNova treatment for the same condition will look very different — most of the needles will be in the patient's hand or foot, with two or three points near the eye itself.
Where the method has its strongest specialization
The Boel Method is used for a wide range of conditions, but its strongest reputation — and most documented clinical experience — is in four areas of eye health:
- Age-related macular degeneration (AMD) — both wet and dry forms
- Anterior ischemic optic neuropathy (AION and NAION)
- Retinitis pigmentosa
- Glaucoma — typically as a complement to pharmacological pressure-lowering treatment
These are conditions where conventional ophthalmology often runs out of options. AMD has anti-VEGF injections for wet forms but no curative treatment for dry. AION has no established treatment at all. Retinitis pigmentosa is genetic and progressive. Glaucoma is managed with eye drops that lower intraocular pressure but do not restore lost vision. In each of these cases, patients who have exhausted what mainstream medicine can offer them frequently look to complementary approaches — and the Boel Method's clinical experience with these specific conditions is among the most extensive in the field.
What complementary actually means here
Before going further, the important framing: the Boel Method is a complementary therapy. It is not a substitute for ophthalmological care, surgical intervention where indicated, or medication. A patient with wet AMD receiving anti-VEGF injections does not stop those injections to try acupuncture. A glaucoma patient on eye drops does not stop the drops. The method is applied alongside conventional care, in cases where the patient and their physician agree that there is no contraindication.
This framing matters because the entire conversation about acupuncture and serious eye disease can be derailed by overpromise. Reputable Boel-trained practitioners do not claim to cure macular degeneration. They report — and patients report — improvements in visual function, stabilization of disease that had been progressing, and improvements in subjective quality of vision. Whether those improvements are reproducible at scale, whether they would survive rigorous double-blind testing, and how they compare to a sham-acupuncture control are open questions the available evidence does not fully resolve.
The Acunova protocol
The clinical protocol that the Boel Acupuncture School teaches is structured. A patient does not receive a generic acupuncture treatment; they receive a treatment specifically designed for their condition, in a defined sequence. Treatments are typically delivered in series — often ten sessions, with reassessment, followed by additional series depending on response.
Each treatment lasts roughly 20 to 30 minutes. Needles used are very fine — comparable to or thinner than those used in classical TCM. Stimulation methods vary by protocol; some points receive only insertion, others receive manipulation or low-level electrical stimulation. For practitioners, the protocol is reproducible, which is the key reason it can be taught and transferred.
Who practices the method
Practitioners of the Boel Method are graduates of the Boel Acupuncture School in Denmark or have been trained directly by Boel-school graduates. The school operates from its headquarters in Aulum, Denmark, and trains practitioners from across Europe, North America, and Asia. The Boel clinical network itself consists of seven clinics in Denmark — Aulum, Aarhus, Copenhagen, Odense, Aalborg, Esbjerg, and Haslev — where John Boel Jr. and his team treat patients and where the method is continuously refined through case experience.
Outside Denmark, finding a Boel-trained practitioner can be straightforward in some countries (Germany, the Netherlands, and several Nordic countries have meaningful school-graduate populations) and more difficult elsewhere. The school maintains a directory; practitioners who have completed the training are credentialed to identify themselves as such.
What to expect if you are exploring the method
If you are considering the Boel Method for a condition you or a family member is dealing with, the realistic framing is this:
- The method is a long-term complement, not a quick fix. Series of treatments, repeated over months, is the standard model.
- Response varies. Some patients see clear improvement; others see stabilization; others see neither.
- The method is generally low-risk when performed by a trained practitioner. The most common adverse effects are mild bruising or transient discomfort at needle sites.
- It does not replace medical care. Continue ophthalmological monitoring. Take prescribed medications. Use the method alongside, not instead.
- The earlier a condition is addressed, the more clinical experience suggests there is to work with. Late-stage advanced disease responds less consistently than earlier presentations.
In future articles, I will look more closely at the specific conditions the method addresses — what the protocols target, what patients can realistically expect, and what the available clinical evidence does and doesn't tell us.